Literature DB >> 20636107

Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activator.

Hong-Yan Huang1, Ze-Fei Jiang, Qing-Xia Li, Jia-Yun Liu, Tao Wang, Rui Zhang, Jing Zhao, Yan-Ming Xu, Wei Bao, Yong Zhang, Lin-Tao Jia, An-Gang Yang.   

Abstract

Urokinase plasminogen activator (uPA) correlates closely with breast cancer metastasis via triggering the degradation of divergent matrix proteins. Here, uPA was selectively knocked down in breast carcinoma MDA-MB-231 cells by siRNAs. The in vitro migration of MDA-MB-231 cells was effectively suppressed accompanied by a decrease in extracellular MMP-9 activities. The colony formation ability of MDA-MB-231 cells was inhibited following uPA knockdown, while the proliferation was not affected. The uPA knockdown in MDA-MB-231 cells caused significantly suppressed tumor metastasis in nude mice. Thus, siRNAs targeted to uPA have implications in the development of novel approaches to preventing breast cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20636107     DOI: 10.3109/07357901003735642

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  9 in total

1.  Fluid shear stress stimulates breast cancer cells to display invasive and chemoresistant phenotypes while upregulating PLAU in a 3D bioreactor.

Authors:  Caymen M Novak; Eric N Horst; Charles C Taylor; Catherine Z Liu; Geeta Mehta
Journal:  Biotechnol Bioeng       Date:  2019-08-01       Impact factor: 4.530

Review 2.  Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches.

Authors:  Muhammad Tufail; Jia Cui; Changxin Wu
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

3.  TGF-β1 alters microRNA profile in human gastric cancer cells.

Authors:  Haiyan Zhou; Kuansong Wang; Zhongliang Hu; Jifang Wen
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

4.  Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effects.

Authors:  Yuqi Jing; Krisztina Kovacs; Vittal Kurisetty; Zhijie Jiang; Nick Tsinoremas; Jaime R Merchan
Journal:  Mol Cancer Res       Date:  2012-08-21       Impact factor: 5.852

Review 5.  Targeting the Notch signaling pathway in cancer therapeutics.

Authors:  Huajiao Guo; Yi Lu; Jianhua Wang; Xia Liu; Evan T Keller; Qian Liu; Qinghua Zhou; Jian Zhang
Journal:  Thorac Cancer       Date:  2014-10-23       Impact factor: 3.500

6.  Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes.

Authors:  Anuradha Moirangthem; Banashree Bondhopadhyay; Mala Mukherjee; Arghya Bandyopadhyay; Narendranath Mukherjee; Karabi Konar; Shubham Bhattacharya; Anupam Basu
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

7.  Metformin is a Novel Suppressor for Vimentin in Human Gastric Cancer Cell Line.

Authors:  Shiva Valaee; Mehdi Shamsara; Mohammad Mehdi Yaghoobi
Journal:  Int J Mol Cell Med       Date:  2022-01-10

8.  Improved therapeutic efficacy of quercetin-loaded polymeric nanoparticles on triple-negative breast cancer by inhibiting uPA.

Authors:  Yang Zhou; Dan Chen; Guangpu Xue; Shujuan Yu; Cai Yuan; Mingdong Huang; Longguang Jiang
Journal:  RSC Adv       Date:  2020-09-17       Impact factor: 4.036

9.  Roles of the Na+/H+ Exchanger Isoform 1 and Urokinase in Prostate Cancer Cell Migration and Invasion.

Authors:  Xiuju Li; Benjamin Buckley; Konstantin Stoletov; Yang Jing; Marie Ranson; John D Lewis; Mike Kelso; Larry Fliegel
Journal:  Int J Mol Sci       Date:  2021-12-09       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.